Search - tctmd.com

Displaying 21 - 40 of 1171

Sort: Relevancy | Date

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

News Industry News

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

November 19, 2025

News Conference News AHA 2025

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Caitlin E. Cox

November 10, 2025

News Conference News AHA 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Todd Neale

November 09, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

Presenter: Hriday Shah

October 27, 2025

Presentation TCT 2025

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

Presenter: Zaid Ali Abdulelah

October 27, 2025

Presentation TCT 2025

TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease

Presenter: Francesco Giannini

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Daily News

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Todd Neale

October 03, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Disconnect Exists Between What Patients Hear vs What Clinicians Try to Say

Caitlin E. Cox

September 16, 2025

Advertisement

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease

TTVR Remains Safe, Effective in Presence of CIED Leads

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Risk Factors Present in Nearly All Patients Who Develop CVD

September 2025 Dispatch for the CV Team

CVD Still the Leading Cause of Death and Disease Globally

Disconnect Exists Between What Patients Hear vs What Clinicians Try to Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content